Valacyclovir
Treatment for Shingles
Typical Dosage: 1000 mg three times daily for 7 days
Effectiveness
90%
Safety Score
75%
Clinical Trials
23
Participants
35K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
1000 mg three times daily for 7 days
Time to Effect
1-3 days for symptom improvement
Treatment Duration
7 days
Evidence Quality
HIGHNumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
100(Treat 100 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$50
Side Effect Mgmt:$10
Total Annual:$90
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$25,000/QALY
QALYs Gained
0.07
Outcome-Based Costs
Cost per Responder
$105.88
Cost per Remission
$120
Comparison vs Acyclovir
Cost Difference
+$15/year
More expensive
QALY Difference
+0.01 QALYs
Better outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$-305
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$120/year
Time Cost
$40/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$30/year
Potential OTC Price
$15/year
Estimated if OTC available
Early Treatment Benefit
+0.02 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
MODERATEValacyclovir Outcomes
for Shingles
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+85%
Remission Rate
+75%
Common Side Effects
Nausea
+18%
Headache
+18%
Vomiting
+8%
Diarrhea
+8%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
15 completed trials for Valacyclovir in Shingles
A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
NCT00900783COMPLETEDPHASE2
350 participants
INTERVENTIONAL
Started: May 1, 2009
Valacyclovir in Immunocompromised Children
NCT00059592COMPLETEDPHASE1
37 participants
INTERVENTIONAL
Philadelphia, United States +1 more
Started: Apr 7, 1998
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
NCT01132716COMPLETEDNA
48 participants
INTERVENTIONAL
Fargo, United States
Started: Sep 1, 2006
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
NCT01132729COMPLETEDNA
48 participants
INTERVENTIONAL
Fargo, United States
Started: Sep 1, 2006
A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
NCT00831103COMPLETEDPHASE2
373 participants
INTERVENTIONAL
Houston, United States
Started: Nov 1, 2007
A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster
NCT02152800COMPLETEDPHASE4
25 participants
INTERVENTIONAL
Taichung, Taiwan
Started: Apr 1, 2011
Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
NCT00487682COMPLETEDPHASE2
403 participants
INTERVENTIONAL
Chūbu, Japan +4 more
Started: Nov 13, 2007
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
NCT05492591COMPLETEDPHASE2
50 participants
INTERVENTIONAL
Nanjing, China
Started: Oct 11, 2022
Phase III Study of ASP2151 in Herpes Zoster Patients
NCT01959841COMPLETEDPHASE3
751 participants
INTERVENTIONAL
Sapporo, Japan +2 more
Started: Aug 1, 2013
Zoster Eye Disease Study
NCT03134196COMPLETEDPHASE4
527 participants
INTERVENTIONAL
Birmingham, United States +77 more
Started: Aug 23, 2017
Reduction of Postherpetic Neuralgia in Herpes Zoster
NCT01250561COMPLETEDNA
133 participants
INTERVENTIONAL
Houston, United States
Started: Feb 1, 2002
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
NCT00006131COMPLETEDNA
66 participants
INTERVENTIONAL
Houston, United States
Started: Jan 1, 1997
Palatability Testing of a New Paediatric Formulation of Valacyclovir
NCT01682109COMPLETEDPHASE4
41 participants
INTERVENTIONAL
Nijmegen, Netherlands
Started: Sep 1, 2012
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
NCT01689285COMPLETEDPHASE1
16 participants
INTERVENTIONAL
Nijmegen, Netherlands
Started: Dec 1, 2013
Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)
NCT01390857COMPLETED
379 participants
OBSERVATIONAL
Started: Nov 1, 2007
Showing 20 of 24 total trials